Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?JOURNAL OF ALZHEIMERS DISEASEIF3.12025-02-1027PREAI
miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple SclerosisCELLSIF5.22022-05-0514OAAI
Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damageALZHEIMERS RESEARCH & THERAPYIF7.62022-02-1212OAAI
Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosisNEUROIMAGE-CLINICALIF3.62022-01-0130OAAI
Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic SyndromeJOURNAL OF ALZHEIMERS DISEASEIF3.12021-01-192PREAI
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromesALZHEIMERS RESEARCH & THERAPYIF7.62019-10-1529OAAI
Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu-Hakola DiseaseCYTOKINEIF3.72019-04-014PREAI
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF -amyloid levels and brain volumesEuropean Journal of Nuclear Medicine and Molecular ImagingIF7.62018-10-2129PREAI
CSF β-amyloid predicts prognosis in patients with multiple sclerosisMULTIPLE SCLEROSIS JOURNALIF52018-08-0724OAAI
EVIDENCE OF CNS β-AMYLOID DEPOSITION IN NASU-HAKOLA DISEASE DUE TO THE TREM2 Q33X MUTATIONNEUROLOGYIF8.52017-12-1225PREAI
Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference?JOURNAL OF ALZHEIMERS DISEASEIF3.12017-11-2811PREAI
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patientsMULTIPLE SCLEROSIS JOURNALIF52017-11-1044OAAI
CSF β-amyloid and white matter damage: a new perspective on Alzheimer's diseaseJOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRYIF7.52017-10-2043OAAI
Merkel cell carcinoma in a patient with relapsing-remitting multiple sclerosis treated with fingolimodJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22017-10-013PREAI
Recognition of viral and self-antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapsesJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22017-09-0161OAAI
CSF -amyloid as a putative biomarker of disease progression in multiple sclerosisCSF-淀粉样蛋白作为多发性硬化症疾病进展的推定生物标志物MULTIPLE SCLEROSIS JOURNALIF52016-10-1731OAAI
Reversible Parkinson's Dementia Associated with Withdrawal of Androgen-Deprivation Therapy for Prostate CancerJOURNAL OF THE AMERICAN GERIATRICS SOCIETYIF4.52016-08-263OAAI
C9ORF72 repeat expansion not detected in patients with multiple sclerosisNEUROBIOLOGY OF AGINGIF3.52014-05-0111PREAI
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosisMULTIPLE SCLEROSIS JOURNALIF52013-11-25102PREAI
A 66-YEAR-OLD PATIENT WITH VANISHING WHITE MATTER DISEASE DUE TO THE p.Ala87Val EIF2B3 MUTATIONNEUROLOGYIF8.52012-11-1322PREAI